MedTrace Logo

Safety and Tolerability Study of the Taris Placebo System

NCT01051336 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-01-18

No results posted yet for this study

Summary

The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.

Conditions

  • Healthy

Interventions

DEVICE

TARIS Placebo

PROCEDURE

Sham Procedure

Sponsors & Collaborators

  • TARIS Biomedical, Inc.

    lead INDUSTRY

Principal Investigators

  • Pankaj M Jain, M.D., M.B.A. · Dedicated Phase I (Arizona Urology)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01051336 on ClinicalTrials.gov